| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | AK | AL | AM | AN | AO | AP | AQ | AR | AS | AT | AU | AV | AW | AX | AY | AZ | BA | BB | BC | BD | BE | BF | BG | BH | BI | BJ | BK | BL | BM | BN | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Field name | Field programmatic name | Description | Data type | Categorical values (ontology and enum) | Examples | Required | Imported from bionetwork | Encoded by sample, cell, donor, dataset, library (or combination) | Public / DB side | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | 1 | Age value | age_value | Age of donor at the time of sample collection. Specify the age unit (week, month, year) in age_unit. | integer | N/A | 20; 32; 56 | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | 2 | Age unit | age_unit | Age unit (week, month, year) for the age_value. | string | day; week; month; year | day; week; month; year | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | 3 | Gender identity selfreported | genderidentity_selfreported | Donor self-reported gender identity. | string | N/A | Female Gender; Male Gender; Non-Binary Gender; Other Gender; Agender; Gender Fluid; Gender Identifier X; Genderqueer; Transgender; Two-spirit | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | 4 | Body mass index | bmi | Body mass index of the donor at the time of collection. | integer | N/A | 36.4; 19.2; 27 | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | 5 | Height | height | Height of donor in cm at the time of collection. | integer | N/A | 160; 137; 203 | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | 6 | Weight | weight | Weight of donor in kilograms at the time of collection. | integer | N/A | 50; 80 | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | 7 | Ethnicity self reported | ethnicity_selfreported_freetext | Donor self-reported ethnicity (or ethnicities) in free-text; can include tribe, dialect group, etc. If race information is submitted under this field, please ensure that the question(s) and response options posed to donors are included in the next metadata category (“ethnicity_question_text”). Separate multiple entries with a comma. | string | N/A | PRIORITISED | Genetic Diversity | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | 8 | Ethnicity question text | ethnicity_question_text | Question and response options posed to donors for collecting metadata on donor self-reported ethnicity and / or tribe and / or dialect group and / or race etc. | string | N/A | “What is your ethnicity?”; “Are you Hispanic/Latino?”; Example from All of Us “Which categories describe you? Select all that apply. Note You may select more than one group. American Indian or Alaska Native (for example, Aztec, Blackfeet Tribe, Mayan, Navajo Nation, Native Village of Barrow (Utqiagvik) Inupiat Traditional Government, Nome Eskimo Community, etc.)* Asian (for example, Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese, etc.)* Black, African American, or African (for example, African American, Ethiopian, Haitian, Jamaican, Nigerian, Somali, etc.)* Hispanic, Latino, or Spanish (for example, Columbian, Cuban, Dominican, Mexican or Mexican American, Puerto Rican, Salvadoran, etc.)* Middle Eastern or North African (for example, Algerian, Egyptian, Iranian, Lebanese, Moroccan, Syrian, etc.)* Native Hawaiian or other Pacific Islander (for example, Chamorro, Fijian, Marshallese, Native Hawaiian, Tongan, etc.)* White (for example, English, European, French, German, Irish, Italian, Polish, etc.)* None of these fully describe me (optional free text answer) Prefer not to answer” not collected, not available | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | 9 | Smoking status | smoking_status | If the donor smokes/smoked or not. | string | active; former; never | active; former; never | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | 10 | Years since smoking cessation | years_since_smoking_cessation | If smoking status is "former", specify the number of years since smoking cessation, if available. | integer | N/A | 1; 4; 12 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | 11 | Smoking pack years | smoking_pack_years | Estimated number of packs (20 cigarettes) smoked per day multiplied by the number of years subject was smoking. | integer | N/A | 4.55; 12; 49.5 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | 12 | Household smoking exposure | household_smoking_exposure | If the donor is exposed to passive smoking in their household or not (excluding if they are the ones smoking). | string | yes; no | yes; no | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | 13 | Vaping status | vaping_status | If the donor vapes/vaped or not. | string | active; former; never | active; former; never | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | 14 | Inhaled marijuana status | marijuana_inhaled_status | If the donor inhales or smokes marijuana, in the present, past or never. | string | active; former; never | active; former; never | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | 15 | Comorbidities | comorbidities_ontology_term_id | Indicate all comorbidities/ secondary diagnoses of the donor (primary diagnosis was asked in disease_ontology_term_id field of tier 1 metadata). This must be a MONDO term. Separate multiple entries with a comma. | string | MONDO ontology term | MONDO:0005044; MONDO:0005148 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | 16 | Medication in last month | medication_within_last_month_pre_sample | Please indicate the last known therapy, as drug categories from the NCIT ontology, administered to the patient within the last month prior to sample collection. If this information is not shareable due to data privacy restrictions, please indiciate "not_shareable". | string | NCIT ontology term | NCIT:C389; NCIT:C71534; NCIT:C78113; not_shareable | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | 17 | Diet meat consumption | diet_meat_consumption | Dietary patterns of donor – meat (chicken, seafood, fish, pork, lamb, beef, etc.) consumption versus meat-free diet – at time of sample collection. Fill yes if donor consumes meat or no if donor does not consumes meat. | string | yes; no | yes; no | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | 18 | Primary language | language_donor_primary_language | Primary language(s), spoken by donor. Can include dialects (for example, Hokkien). | string | N/A | Mandarin Chinese; Hokkien; Bahasa Melayu; Tamil; Hausa; Yoruba; Swahili | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | 19 | Current residence location country state | geography_currentresidence_location_country_state | Country and state of donor’s current residence at time of sample collection. | string | N/A | Singapore; United Kingdom; Massachusetts USA; New South Wales Australia; Bauchi State; Nigeria | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | 20 | Current residence location granular | geography_currentresidence_location_granular | Nearest city, town, or village to location of donor’s current residence at time of sample collection. | string | N/A | Singapore; Cambridge; Boston; Kingston | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | 21 | Collection site latitude longitude | geography_collectionsite_latitude_longitude | Latitude and longitude GPS coordinates of collection site in decimal degrees. Please specify latitude followed by longitude separated with a comma. | string | N/A | 1.3,103.8; not_sharable | PRIORITISED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | 22 | Sample collection time point | sample_collection_time_point | Time point when the sample was collected, indicated as YYYY/MM/DD. If this information is not sharable, please indiciate "not_shareable". | date | N/A | 2022/10/29; not_shareable | PRIORITISED | sample | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | 23 | Tissue dissociation protocol | protocol_tissue_dissociation | The dissociation process that was used for the dissociation. | string | Collagenase D + DNAse; Dispase + collagenase; Cold protease 1h; Collagenase + Elastase + DNAse; Cold protease overnight; Collagenase A + DNAse; Mechanical dissociation (chilled) + detergent-based nuclei isolation; Mechanical dissociation (frozen) + citric-acid based nuclei isolation; other | Collagenase D + DNAse; Dispase + collagenase; Cold protease 1h; Collagenase + Elastase + DNAse; Cold protease overnight; Collagenase A + DNAse; Mechanical dissociation (chilled) + detergent-based nuclei isolation; Mechanical dissociation (frozen) + citric-acid based nuclei isolation; other | PRIORITISED | sample | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | 24 | Tissue dissociation protocol free text | protocol_tissue_dissociation_free_text | A free text option to describe dissociation process if not listed in available options. | string | N/A | Collagenase IV and I at 37°C for 8h | PRIORITISED | sample | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | 25 | Pft method | PFT_method | Indicate which Pulmonary Function Testings (PFTs) methods were performed. Please indicate all tests performed. | string | spirometry; plethysmography; DLCO_KCO_test | spirometry; plethysmography; DLCO_KCO_test | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | 26 | Age at pft | age_at_PFT | Indicate the age of the subject at the time point of pulmonary function parameter assessment in years, if known. | integer | N/A | 45; 77; 32 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | 27 | Pft time point | PFT_time_point | Indicate at which date the Pulmonary Function Testing (PFT) were recorded as YYYY-MM-DD if available. If this information is not shareable, please indicate 'not_shareable'. | string | N/A | 2024-11-14; 2019-01-31; not_shareable | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | 28 | Pft relative time point | PFT_relative_time_point | If timepoint of sample collection (sample_collection_time_point) and/or timepoint of PFT recording (PFT_time_point) is not available, indicate how many days prior or after sample collection the pulmunary function parameters were assessed if available. E.g. if PFT recording 5 days prior to sample collection corresponds to "-5", on the day of sample collection "0" and three days after sample collection "3". | integer | N/A | 0; -5; 12 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | 29 | Fev1 milliliters predicted | FEV1_milliliters_predicted | Indicate the predicted Forced Expiratory Volume in 1 second (FEV1) in milliliters, based on patient age, sex, height, and ethnicity, if available. | integer | N/A | 3500; 4200; 2800 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | 30 | Fev1 milliliters prebd | FEV1_milliliters_preBD | Indicate the measured FEV1 in milliliters before the administration of a bronchodilator if available. | integer | N/A | 3500; 4200; 2800 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | 31 | Fev1 milliliters postbd | FEV1_milliliters_postBD | Indicate the measured FEV1 in milliliters after the administration of a bronchodilator if available. | integer | N/A | 3500; 4200; 2800 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | 32 | Fev1 percent of predicted prebd | FEV1_percent_of_predicted_preBD | Indicate the percentage of the predicted FEV1 achieved before bronchodilator administration if available. | integer | N/A | 80; 78; 105 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
34 | 33 | Fev1 percent of predicted postbd | FEV1_percent_of_predicted_postBD | Indicate the percentage of the predicted FEV1 achieved after bronchodilator administration if available. | integer | N/A | 80; 78; 105 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35 | 34 | Fvc milliliters predicted | FVC_milliliters_predicted | Indicate the predicted Forced Vital Capacity (FVC) in milliliters, based on patient age, sex, height, and ethnicity, if available. | integer | N/A | 4500; 5000; 3800 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36 | 35 | Fvc milliliters prebd | FVC_milliliters_preBD | Indicate the measured FVC in milliliters before bronchodilator administration if available. | integer | N/A | 4000; 4800; 3600 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | 36 | Fvc milliliters postbd | FVC_milliliters_postBD | Indicate the measured FVC in milliliters after bronchodilator administration if available. | integer | N/A | 4200; 5000; 3700 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | 37 | Fvc percent of predicted prebd | FVC_percent_of_predicted_preBD | Indicate the percentage of the predicted FVC achieved before bronchodilator administration if available. | integer | N/A | 89; 96; 95 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
39 | 38 | Fvc percent of predicted postbd | FVC_percent_of_predicted_postBD | Indicate the percentage of the predicted FVC achieved after bronchodilator administration if available. | integer | N/A | 93; 100; 97 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 | 39 | Fev1 fvc ratio prebd | FEV1_FVC_ratio_preBD | Indicate the ratio of FEV1 to FVC before bronchodilator administration if available. | integer | N/A | 0.75; 0.79; 0.72 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41 | 40 | Fev1 fvc ratio postbd | FEV1_FVC_ratio_postBD | Indicate the ratio of FEV1 to FVC after bronchodilator administration if available. | integer | N/A | 0.76; 0.80; 0.73 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42 | 41 | Frc abs milliliters | FRC_abs_milliliters | Indicate the Functional Residual Capacity (FRC) in absolute milliliters if available. | integer | N/A | 3000; 3500; 2700 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43 | 42 | Frc percent of predicted | FRC_percent_of_predicted | Indicate the percentage of the predicted FRC, based on patient demographics, if available. | integer | N/A | 95; 88; 102 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | 43 | Rv milliliters | RV_milliliters | Indicate the Residual Volume (RV) in milliliters if available. | integer | N/A | 1500; 1800; 1400 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45 | 44 | Rv percent of predicted | RV_percent_of_predicted | Indicate the percentage of the predicted RV, based on patient demographics, if available. | integer | N/A | 80; 90; 85 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46 | 45 | Ic milliliters | IC_milliliters | Indicate the Inspiratory Capacity (IC) in milliliters if available. | integer | N/A | 3500; 4000; 3200 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47 | 46 | Ic percent of predicted | IC_percent_of_predicted | Indicate the percentage of the predicted IC, based on patient demographics, if available. | integer | N/A | 92; 85; 97 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | 47 | Dlco milliliters | DLCO_milliliters | Indicate the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) in milliliters if available. | integer | N/A | 25; 30; 22 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
49 | 48 | Dlco percent of predicted | DLCO_percent_of_predicted | Indicate the percentage of the predicted DLCO, based on patient demographics, if available. | integer | N/A | 88; 95; 82 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
50 | 49 | Kco mmol min kpa l | KCO_mmol_min_kPa_L | Indicate the transfer coefficient of the lung for carbon monoxide (KCO) in mmol/min/kPa/L if available. | integer | N/A | 5; 6; 4.5 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
51 | 50 | Kco percent of predicted | KCO_percent_of_predicted | Indicate the percentage of the predicted KCO, based on patient demographics, if available. | integer | N/A | 90; 98; 85 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
52 | 51 | Gold stage | GOLD_stage | If donor has COPD, indicating current GOLD stage. | string | 1; 2; 3; 4 | 1; 2; 3; 4 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
53 | 52 | Mmrc grade | mMRC_grade | If donor has COPD, indicate the Modified British Medical Research Council (mMRC) dyspnea scale grade if available. | string | 0; 1; 2; 3; 4 | 0; 1; 2; 3; 4 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
54 | 53 | Cat score | CAT_score | If donor has COPD, indicate the COPD Assessment Test (CAT) score if available. | string | N/A | 2; 5; 37 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
55 | 54 | Gold abe assessment | GOLD_ABE_assessment | If donor has COPD, indicate the Global Initiative for Chronic Obstructive Lung Disease (GOLD) A, B, C, D assessment group if available. | string | A; B; E | A; B; E | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | 55 | Copd phenotype | COPD_phenotype | If donor has COPD, indicate the COPD disease phenotype(s) of donor. Please indicate all applicable phenotypes of donor | string | COPD not otherwise specified; COPD with emphysema; COPD with bronchitis; COPD with history of asthma; COPD with >300 eos in blood; COPD with allergy; COPD with Chronic Mucus; Hypersecretion; COPD with frequent exacerbations | COPD not otherwise specified; COPD with emphysema; COPD with bronchitis; COPD with history of asthma; COPD with >300 eos in blood; COPD with allergy; COPD with Chronic Mucus; Hypersecretion; COPD with frequent exacerbations | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
57 | 56 | Percentage of emphysema | percentage_of_emphysema | If donor has COPD, Indicate the percentage of the lung that is affected by emphysema as judged based on non-invasive imaging, such as from a CT scan. | integer | N/A | 18; 37; 63 | PRIORITISED | donor | controlled access available | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
58 | 57 | Current residence duration | geography_currentresidence_duration | Duration of residence, in years, rounded up to the nearest whole number, at time of sample collection. | integer | N/A | 20; 37; 45-65 | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
59 | 58 | Current residence type urbanrural | geography_currentresidence_urbanrural | Urban, suburban, or rural descriptor of current residence. | string | urban; suburban; rural | urban; suburban; rural | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
60 | 59 | Place of birth location - country state | geography_placeofbirth_location_country_state | Country and state of place of birth. | string | N/A | Singapore; United Kingdom; Massachusetts USA; New South Wales Australia; Bauchi State; Nigeria | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
61 | 60 | Place of birth location - granular | geography_placeofbirth_location_granular | Nearest city, town, or village to location of place of birth. | string | N/A | Singapore; Cambridge; Boston; Kingston | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
62 | 61 | Place of birth duration | geography_placeofbirth_duration | Duration of residence, in years, rounded up to the nearest whole number. | integer | N/A | 20; 37; 45-65 | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | 62 | Place of birth type urbanrural | geography_placeofbirth_urbanrural | Urban, suburban, or rural descriptor of place of birth. | string | urban; suburban; rural | urban; suburban; rural | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
64 | 63 | Ethnicity parents selfreported | ethnicity_parents_selfreported_freetext | Donor’s parents’ self-reported ethnicity (or ethnicities) in free-text; can include tribe, dialect group, etc. Separate multiple entries with a comma. | string | N/A | Singaporean Chinese; Singaporean Malay; Singaporean Indian; Haitian; Nigerian Hausa; Ghana Hausa; Benin Kanuri; Nigerian Kanuri; Igbo; Luo; Herero; Garifuna; Kalinago | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 | 64 | Mother father tongue | language_mother_father_tongue | Ancestral language(s), spoken by parents (“mother tongue” and / or “father tongue”) and / or grandparents. Can include dialects (for example, Hokkien). | string | N/A | Mandarin Chinese; Hokkien; Bahasa Melayu; Tamil; Hausa; Yoruba; Swahili | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | 65 | Menarche age | menarche_age | Age at menarche, rounded to nearest whole number. | integer | N/A | 13; 12; 16 | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
67 | 66 | Menopause status | reproductive_menopause | Menopausal status of donor at time of sample collection. | string | pre-menopausal; peri-menopausal; post-menopausal; post-menopausal (induced); not applicable | pre-menopausal; peri-menopausal; post-menopausal; post-menopausal (induced); not applicable | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
68 | 67 | Number children | reproductive_number_children | Number of children (full-term pregnancies) the donor has given birth to at time of sample collection. | integer | N/A | 0; 2; 3 | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
69 | 68 | Number pregnancies | reproductive_number_pregnancies | Number of pregnancies the donor has had at time of sample collection. | integer | N/A | 2; 3; 5 | RECOMMENDED | Genetic Diversity | donor | controlled access available | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
70 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
73 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
75 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
76 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
78 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
79 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
80 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
82 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
87 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
88 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
90 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
92 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
93 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
94 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
95 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
96 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
97 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
100 |